CD68 and glioma: Thus, the modulation of CD68 expression in accordance with the reduction of cell proliferation measured within the tumor confirms the ability of TRAM-34 to reduce glioma invasiveness since the overexpression of CD68, recently found in several types of cancer, has been correlated with tumor aggressiveness and malignant progression (Zhang et al., 2022).